Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...

Ford executives are increasingly studying all aspects of Chinese automakers and that market as the most intense competition ...

Wistron inaugurated its global operations headquarters at the Zhubei AI park in Hsinchu County on June 19, 2025, with Vice President Bi-khim Louise Hsiao in attendance. Hsiao underscored the strength ...

Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets ...

Amid escalating U.S.-China trade tensions, top Chinese drug research firms like WuXi AppTec and WuXi Biologics (HK:2269) are ...

The consumer landscape in China was very different in the 1990s, when Häagen-Dazs and Starbucks ventured in with premium ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that members of its ...

NURTuRE-AKI is a novel observational study that collects longitudinal data and biological samples from fully consented acute kidney injury ("AKI") patients, developed as part of a research consortium ...

Accra, April 4, GNA – The Minister of Lands and Natural Resources, Mr Emmanuel Armah-Kofi Buah, has inaugurated the Association of China-Ghana Mining (ACGM), to champion sustainable mining, increased ...

The China investment follows a $2 billion new commitment the British pharma is adding to its U.S. operations, which also covers expansions in manufacturing and R&D capabilities, bringing its total ...

Although its drug compound patent in China expired in 2023, AZ’s 2024 annual report revealed that dapagliflozin achieved record-high sales of approximately $500 million (3.5 billion RMB) in China’s ...

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre together with major research and manufacturing agreements that will ...